CrossRef Current and novel modalities for management of chronic hepatitis B infection Iman Ibrahim Salama, Samia M Sami, Somaia I Salama, Ghada A Abdel-Latif, Fatma A Shaaban, Walaa A Fouad, Aida M Abdelmohsen, Hala M Raslan World Journal of Hepatology .2023
Controlled human trials exist, but they're limited in size, focused mostly on topical cosmetic use, and usually last only a few weeks or months. That means a lot of the exciting claims, especially around gene expression, systemic repair, and anti-aging effects, haven't been confirmed in large-scale human studies
Staying on a maintenance dose long-term has been associated with: Lower blood pressure Improved cholesterol levels Cardiovascular protection Freedom from food noise (constant food thoughts) For some patients at their goal weight, microdosing GLP-1 medication can be a helpful strategy for maintaining results, especially if weight loss continues at standard doses, and may also offer supportive cardiometabolic or inflammatory benefits beyond weight alone
The PG gene consists of six exons and five introns, and the active form, GLP-1 (736 amide or 737), functions as a potent incretin
Karen Andersen, an equity strategist at Morningstar and an author of the report, estimated that the current market is about $50 billion
Since the per-protocol approach was used to analyze the data in this sub-study, we cannot be sure that the different groups are still comparable due to unidentified reasons (19), and hence the advantages of randomization might be reduced